TBMIF yields 133333.33% · PFE yields 6.13%● Live data
📍 TBMIF pulled ahead of the other in Year 1
Combined, TBMIF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TBMIF + PFE for your $10,000?
Big Tree Carbon Inc., a mineral exploration company, engages in the acquisition, exploration, and development of gold properties in Ontario, Canada. It owns 100% interests in the Richardson Lake gold property consisting of 123 mineral cell and 5-cell multicell mineral claims covering an area of approximately 2,220 hectares; and the Western Fold properties comprises 110 mineral cell claims totaling approximately 2,170 hectares located in Brownstone and Casummit Lake Area mining townships, as well as the Richardson North Extension Gold property consisting of 50 mineral cell claims covering an area of approximately 1,010 hectares. The company also holds 100% interest in the Dancing Man Gold property comprises 654 mineral cell claims totaling approximately 13,280 hectares; the Ranger Lake gold property consisting of 236 mineral cell claims covering an area of approximately 4,790 hectares; and the McFaulds Lake property totaling 450 hectares located in Northern Ontario. In addition, it holds 35% interest in the Bridget Lake property that covers an area of approximately 144 hectares situated in Northern Ontario. The company was formerly known as AurCrest Gold Inc. and changed its name to Big Tree Carbon Inc. in April 2022. Big Tree Carbon Inc. is based in Toronto, Canada.
Full TBMIF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.